These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7058570)

  • 21. The sympathetic nervous system in hypertension: differing effects of drug treatment.
    Sleight P
    Eur Heart J; 1998 Jun; 19 Suppl F():F39-44. PubMed ID: 9651734
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)].
    Salzmann R; Bürki H; Chu D; Clark B; Marbach P; Markstein R; Reinert H; Siegl H; Waite R
    Arzneimittelforschung; 1979; 29(12):1843-53. PubMed ID: 232662
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of the DL(methylene-dioxy-3-4)phenyl 2 hydroxy-2-acetamidine chlorhydrate (LL-1418) on general hemodynamics and cardiac metabolism].
    Duteil J; Boutet G; Bernard F; Nadaud J; Assous E
    Therapie; 1969; 24(6):1089-101. PubMed ID: 5367186
    [No Abstract]   [Full Text] [Related]  

  • 24. Sympatholytic therapy in primary hypertension: a user friendly role for the future.
    DeQuattro V; Li D
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S118-23. PubMed ID: 11986908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihypertensive agents acting on the nervous system. 1. Physiology].
    Béroniade V
    Union Med Can; 1981 Nov; 110(11):962-6 contd. PubMed ID: 7324269
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sidnofen-induced activation of peripheral adrenergic transmission].
    Babskaia NE
    Patol Fiziol Eksp Ter; 1992; (2):42-4. PubMed ID: 1329003
    [No Abstract]   [Full Text] [Related]  

  • 27. Guanethidine: pharmacokinetics during acute and chronic treatment and influence upon the peripheral sympathetic nervous system.
    Hengstmann JH
    Arch Int Pharmacodyn Ther; 1980; Suppl():17-21. PubMed ID: 7416875
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of hemodynamics in sympathectomized rats after adaptation to tail suspension.
    Kharchenko I; Tarasova O; Zotov A; Borovik A; Vinogradova O
    J Gravit Physiol; 2000 Jul; 7(2):P139-40. PubMed ID: 12697494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. l-alpha-Acetylmethadol (LAAM) attenuates sympathetic function by a peripheral mechanism.
    Stickney JL; Eikenburg DC; Keedy JD
    Proc West Pharmacol Soc; 1981; 24():237-9. PubMed ID: 7255458
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sympatholytics. Principles and rules of use].
    Olive G
    Rev Prat; 1993 Oct; 43(15):1997-2002. PubMed ID: 8310258
    [No Abstract]   [Full Text] [Related]  

  • 32. The importance of the sympathetic nervous system in hypertension. Introduction.
    van Zwieten PA; Julius S
    J Hypertens Suppl; 1999 Aug; 17(3):S1. PubMed ID: 10489091
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of various alpha and beta adrenolytics on vasodilation due to sodium nicotate].
    Laury MC
    C R Seances Soc Biol Fil; 1967; 161(10):1951-4. PubMed ID: 4386455
    [No Abstract]   [Full Text] [Related]  

  • 34. Central cardiovascular effects of drugs.
    Bhargava KP
    Indian J Med Res; 1966 Feb; 54(2):166-77. PubMed ID: 5933286
    [No Abstract]   [Full Text] [Related]  

  • 35. [Does reserpine stimulate the medullary vasomotor centers?].
    Donnet V; Duflot JC; Jacquin M; Peyrot J; Fornaris M
    Pathol Biol (Paris); 1969 Dec; 17(23):1079-82. PubMed ID: 4908014
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of dopamine D2 receptors in the CNS inhibits sympathetic cutaneous vasomotor alerting responses (SCVARs), contributing to clozapine's SCVAR-inhibiting action.
    Blessing WW; Ootsuka Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):328-36. PubMed ID: 17055139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurohormonal activity in heart insufficiency].
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Ugeskr Laeger; 1993 Jun; 155(23):1784-8. PubMed ID: 8317027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central sympatholytic drugs.
    Vongpatanasin W; Kario K; Atlas SA; Victor RG
    J Clin Hypertens (Greenwich); 2011 Sep; 13(9):658-61. PubMed ID: 21896146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.